- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefTM
- Patient Resources
About This Event
The Evolution Of Managing Patients With Anemia Due To Chronic Kidney Disease
Anemia is a well-known complication of chronic kidney disease (CKD) and the overall impact it has on patients who suffer from CKD is significant. In this informative webinar, renowned anemia expert, Dr Jay B Wish, will walk us through how managing patients with anemia in CKD has evolved over time and highlight recent scientific advancements that could potentially change the treatment landscape of anemia in CKD.*Dr Wish is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Mr George is an employee of ODPC.
Indiana University School of Medicine & Indiana University Health*
Jay B Wish, MD, is Professor of Clinical Medicine at Indiana University School of Medicine in Indianapolis and Chief Medical Officer for Dialysis at Indiana University Health. He is past president of the National Forum of End-Stage Renal Disease (ESRD) Networks and has been an advisor to the Centers for Medicare and Medicaid Services (CMS) on quality improvement issues in dialysis. He served on the Board of Directors of the Renal Physicians Association and the American Association of Kidney Patients and was the recipient of the latter’s Visionary Award in 2005. Dr Wish is Vice Chairman of the Editorial Advisory Board for Nephrology News & Issues and on the editorial boards of the Journal of the American Society of Nephrology and Clinical Journal of the American Society of Nephrology. He has had over 100 articles, reviews, and book chapters published, particularly in the areas of ESRD quality oversight/improvement, accountability, anemia management, and vascular access.
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Sean George PA-C, MHS is a Physician Assistant who currently works as a Medical Science Liaison for Otsuka Pharmaceutical Commercialization and Development. He has been with Otsuka in his current role for 2 years supporting the Nephrology division. Prior to joining industry, he practiced in a private practice Nephrology clinic for 4 years managing patients with chronic kidney disease including their associated co-morbidities, anemia secondary to CKD, acute kidney injury, and end stage renal disease. In addition to his clinical work, he served on the Executive Committee for Advanced Practitioners with the National Kidney Foundation for 3 consecutive years as member-at-large, secretary, and research chair. Sean earned his Physician Assistant/Masters Health Science from the University of Oklahoma College of Medicine. He is currently licensed in the state of Oklahoma and certified with the National Commission on Certification of Physician Assistants.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.May 2020 MRC2.CORP.X.04767
February 14 from 12:00 pm to 1:00 pm
- Resource Center
- Patient Resources